Furthermore, the fraction of CD4+/CD25+/CD127low Treg was increased in PBMC of patients compared to healthy controls, suggesting a systemic immunosuppressive activity in HNSCC patients. The gene discussed is CD4; the disease is head and neck squamous cell carcinoma.